Drug intelligence / Profile preview

4-(carboxyvin-2-yl)phenylboronic acid

Development stage
Unknown
Modality
Small Molecules
01

Overview

4-(Carboxyvin-2-Yl)Phenylboronic Acid is a synthetic small molecule containing both a boronic acid and carboxylic acid functional group, with the chemical formula C9H9BO4 and molecular weight of approximately 192 g/mol[1][2][5]. It is primarily studied as an experimental compound and has been used in structural biology as an inhibitor of beta-lactamase enzymes, such as AmpC beta-lactamase from Escherichia coli. The mechanism involves binding to the active site of the enzyme, mimicking transition states or intermediates in enzymatic reactions, thereby inhibiting its function[8][10]. This makes it relevant for research into overcoming bacterial resistance to beta-lactam antibiotics. There are no known approved therapeutic indications or marketed formulations for this compound.

Other names
(2E)-3-[4-(dihydroxyboranyl)phenyl]prop-2-enoic acid(E)-3-(4-boronophenyl)acrylic acid(2E)-3-(4-(dihydroxyboranyl)phenyl)prop-2-enoic acid
02

Targets

AmpC (AmpC beta-lactamase)

Beyond the preview

Go deeper on 4-(carboxyvin-2-yl)phenylboronic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 4-(carboxyvin-2-yl)phenylboronic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call